Back

SCN5A H558R polymorphism reduces the risk of flecainide-related toxicity and inefficacy

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors Rhythm Control, Antiarrhythmic Drugs ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Mauro Trincado Ave

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

5 More presentations in this session

Presentation thumbnail
Peak atrial longitudinal strain in predicting recurrence of atrial fibrillation after cardioversion
Doctor A. Garner (Slagelse, DK)
Abstract Slides Video
Presentation thumbnail
Predictors of long-term atrial fibrillation recurrence following catheter ablation: a UK multicenter study
Doctor N. Chandan (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Baseline multidomain atrial vulnerability stratifies recurrence after AF ablation in elderly patients
Professor D. Malidze (Tbilisi, GE)
Abstract Slides Video
Presentation thumbnail
Plasma level of extracellular matrix biomarkers is associated with the recurrence of atrial fibrillation
Mr S. Andrup (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
REVERSE-AF Score: development of a clinical tool to predict atrial fibrillation recurrence after electrical cardioversion
Doctor M. Santos Silva (Aveiro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
H558R: a common polymorphism may modify the efficacy and toxicity of flecainide in maintaining sinus rhythm; a cohort study.
1 September 2024
thumbnail
Congress Presentation
Extra-pulmonary vein drivers as a potential mechanism of the antiarrhythmic drug-resistant atrial fibrillation after catheter ablation: Digital twin-guided virtual drug test
29 August 2026
thumbnail
Congress Presentation
Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
30 August 2026
thumbnail
Congress Presentation
Phenotype-genotype evaluation of sudden cardiac arrest/ death cohort study
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources